MENU
MNPR Monopar Therapeutics Inc Forecast, Technical & Fundamental Analysis
a clinical stage biopharmaceutical company, which engages in building a drug development pipeline of oncology therapeutics in late preclinical and clinical development stages
Industry Biotechnology
Show more...
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company, which engages in building a drug development pipeline of oncology therapeutics in late preclinical and clinical development stages
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1000 Skokie Boulevard
Phone
+1 847 388-0349
Employees
10
Web
https://www.monopartx.com
Interesting Tickers
MNPR and Stocks
Correlation & Price change
A.I.dvisor tells us that MNPR and MPSYF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MNPR and MPSYF's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To MNPR | 1D Price Change % | ||
|---|---|---|---|---|
| MNPR | 100% | -5.20% | ||
| MPSYF - MNPR | 29% Poorly correlated | N/A | ||
| DBVT - MNPR | 27% Poorly correlated | -9.68% | ||
| QNCX - MNPR | 27% Poorly correlated | +19.50% | ||
| RAPT - MNPR | 26% Poorly correlated | -18.47% | ||
| BNOX - MNPR | 25% Poorly correlated | +8.20% | ||
More | ||||